Is AMN Healthcare profitable in 2026?

Yes on paper: Q1 2026 adjusted EBITDA was $166 million (12.1% margin) with GAAP EPS of $1.59, reported May 7, 2026. But most of the revenue spike came from one-off $722 million strike-coverage demand, and Q2 2026 is guided down 4-6% YoY, so underlying profitability is weaker than headline numbers suggest.

Is AMN Healthcare laying off workers?

AMN's corporate headcount fell to 2,664 at year-end 2025, down 10.2% from 2,968 the prior year and down roughly 37% from a 2022 peak of about 4,230, per stockanalysis.com data as of June 23, 2026, reflecting a multi-year structural contraction.

Could AI replace AMN Healthcare's staffing business?

AI-native platforms like DirectShifts and Pflegia are directly targeting AMN's core clinician-matching workflow; Pflegia received a majority PE investment from Ardian in mid-July 2026. Equity researchers described AMN's own AI as a 'gradual efficiency boost' rather than a step-change, as of July 9, 2026.

Who is AMN Healthcare's biggest competitor?

Aya Healthcare, the largest US healthcare staffing firm with $6.9 billion in 2024 staffing revenue (16.1% share), well ahead of AMN, which ranked 4th behind Aya, CHG Healthcare, and Jackson Healthcare per an August 13, 2025 Staffing Industry Analysts report.

Who owns AMN Healthcare?

AMN Healthcare Services, Inc. is publicly traded on the NYSE under ticker AMN with no parent company. Its market capitalization was approximately $1.33 billion as of a July 22, 2026 data snapshot.

What is AMN Healthcare's stock doing in 2026?

AMN shares traded around $34.13 on July 21, 2026, up roughly 130% year-to-date, within a 52-week range of $14.87 to $36.27, though far below its all-time high of $129.12.

Job boards and HR platforms · United States

AMN Healthcare

amnhealthcare.com ↗

Staffing company that matches nurses and clinicians to hospital shifts nationwide.

Losing its protection

Assessed 22 July 2026 · Evidence as of 22 July 2026

The structural protection is eroding.

On the recordSince 22 July 2026 · Checkable from Aug 6, 2026 · Every call on the record Checkpoint: Q2 2026 earnings call: does normalized revenue hold near guided 4-6% YoY decline

The call

AMN's contracts keep hospitals tied in for now, but Aya Healthcare and AI-native platforms are quietly eating the shift-matching work AMN was built on.

AMN Healthcare matches doctors and nurses to hospital shifts and takes a cut. It sounds hard to replace because it has contracts with 93% of top US hospitals, but that lock-in is weakening: Aya Healthcare, a bigger competitor, just launched an AI system that does the same work faster, and new startups like DirectShifts are letting hospitals hire nurses directly without a middleman. AMN's revenue fell 8.5% last year, its payroll is down 37% since 2022, and hospitals are starting to hire recruiting staff themselves instead of using brokers. The question that matters most is whether hospitals will renew their contracts with AMN at current prices when the next round comes up, or whether they will switch to AI systems or handle recruiting in-house.

Why

AI pressure: DirectShifts and Pflegia (AI-native direct-to-clinician platforms). AI tools let hospitals book clinicians directly, skipping AMN's matching fee and markup on every shift filled. Could AI do the core job? Only partly.

Bigger players: Aya Healthcare. Aya, 2.5 times AMN's scale, already shipped an AI-driven VMS and keeps pulling staffing volume away. Could a giant copy it? Yes, easily.

What protects it. Multi-year MSP and VMS contracts keep AMN wired into 93% of top health systems, buying a few years before renewal risk bites.

What would change this call

Q2 2026 earnings (Aug 6, 2026) show ex-strike revenue decline worse than the guided 4-6%. Underlying demand is eroding faster than management projected.
MSP contract renewals lost to Aya Healthcare or shift to in-house hospital recruiting tools. Core distribution lock-in is weakening, not just cyclically soft.
Technology & Workforce Solutions segment revenue misses the -14% to -16% guided range further downward. AI-native rivals like DirectShifts or Pflegia are displacing AMN's tech offerings.

Key numbers

Q1 2026 revenue $1.378B, up 100% YoY on strike coverage (2026-05-07)
FY2025 revenue fell 8.5% to $2.73B (2026-03-14)
Headcount down 37% since 2022 peak, now 2,664 (2026-06-23)

Named risks

Q1 2026 revenue growth driven by one-off $722M strike coverage masking underlying decline. Severity: high
Corporate headcount down 37% since 2022 peak signals structural business contraction. Severity: medium
AI-native entrants DirectShifts and Pflegia directly target AMN's core clinician-matching workflow. Severity: high
Hospitals increasingly building internal recruiting, reducing reliance on staffing agencies. Severity: medium
Ongoing employment litigation including Franklin v. AMN Healthcare Labor Disruption filed Dec 2025. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Aya Healthcare	losing to	Aya had $6.9B 2024 revenue vs AMN ranked 4th, and shipped AI VMS LotusOne in July 2024
CHG Healthcare	losing to	CHG ranked 2nd with $2.8B revenue vs AMN 4th, as of Aug 2025 SIA report
Jackson Healthcare	losing to	Jackson ranked 3rd with $2.5B revenue ahead of AMN as of Aug 2025
DirectShifts	contesting	AI-native direct-to-clinician platform marketed as lower-cost alternative to AMN's agency model
Pflegia	gaining on	Received majority PE investment from Ardian mid-July 2026, signaling AI-staffing momentum

Questions people ask

Is AMN Healthcare profitable in 2026?: Yes on paper: Q1 2026 adjusted EBITDA was $166 million (12.1% margin) with GAAP EPS of $1.59, reported May 7, 2026. But most of the revenue spike came from one-off $722 million strike-coverage demand, and Q2 2026 is guided down 4-6% YoY, so underlying profitability is weaker than headline numbers suggest.
Is AMN Healthcare laying off workers?: AMN's corporate headcount fell to 2,664 at year-end 2025, down 10.2% from 2,968 the prior year and down roughly 37% from a 2022 peak of about 4,230, per stockanalysis.com data as of June 23, 2026, reflecting a multi-year structural contraction.
Could AI replace AMN Healthcare's staffing business?: AI-native platforms like DirectShifts and Pflegia are directly targeting AMN's core clinician-matching workflow; Pflegia received a majority PE investment from Ardian in mid-July 2026. Equity researchers described AMN's own AI as a 'gradual efficiency boost' rather than a step-change, as of July 9, 2026.
Who is AMN Healthcare's biggest competitor?: Aya Healthcare, the largest US healthcare staffing firm with $6.9 billion in 2024 staffing revenue (16.1% share), well ahead of AMN, which ranked 4th behind Aya, CHG Healthcare, and Jackson Healthcare per an August 13, 2025 Staffing Industry Analysts report.
Who owns AMN Healthcare?: AMN Healthcare Services, Inc. is publicly traded on the NYSE under ticker AMN with no parent company. Its market capitalization was approximately $1.33 billion as of a July 22, 2026 data snapshot.
What is AMN Healthcare's stock doing in 2026?: AMN shares traded around $34.13 on July 21, 2026, up roughly 130% year-to-date, within a 52-week range of $14.87 to $36.27, though far below its all-time high of $129.12.

Timeline

2026-07-16Rival AI staffing platform Pflegia takes majority PE investment from Ardian
2026-06-15Kristy Willis named CCO, Holly Novak named CPO effective this date
2026-06-11AMN acquires Jaide Health, an AI-assisted language-support platform
2026-05-07Q1 2026 revenue hits $1.378B, up ~100% YoY, $722M from strike coverage
2026-05-01Shareholder proposal for independent board chair fails at AGM
2026-02-19Q4/FY2025 results show full-year revenue down 8.5% YoY
2025-08-13Staffing Industry Analysts ranks AMN 4th in US healthcare staffing
2025-07AMN divests Smart Square workforce-management software business
2024-07Aya Healthcare launches AI-driven VMS product LotusOne

Revision history

22 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Deel Beisen Holdings Saramin HR